• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高效液相色谱-荧光检测法同时测定血浆中普萘洛尔对映体

Simultaneous determination of propranolol enantiomers in plasma by high-performance liquid chromatography with fluorescence detection.

作者信息

Prakash C, Koshakji R P, Wood A J, Blair I A

机构信息

Department of Pharmacology, Vanderbilt University, School of Medicine, Nashville, TN 37232.

出版信息

J Pharm Sci. 1989 Sep;78(9):771-5. doi: 10.1002/jps.2600780915.

DOI:10.1002/jps.2600780915
PMID:2585274
Abstract

A simple, rapid, and sensitive assay for the simultaneous quantification of the (-)- and (+)-propranolol in human and dog plasma is described using a reversed-phase high-performance liquid chromatography (HPLC) system with fluorescence detection. The method involves extraction of propranolol enantiomers from plasma into 1% 1-butanol in n-hexane at basic pH, followed by evaporation of the organic phase and the formation of diastereomeric derivatives with the chiral reagent (-)-menthyl chloroformate. (+)-Flecainide is used as the internal standard. The limiting concentration of each enantiomer that can be detected is 1 ng/mL plasma. In six normal human volunteers, who received a single oral dose of 80 mg of racemic propranolol, the plasma levels of the (-)-enantiomer were always higher than those of the (+)-enantiomer with a mean (-):(+) ratio of 1.38. The half-lives of both the enantiomers were similar (3.5 +/- 0.3 h). In six normal male mongrel dogs given a single intraportal dose of 40 mg of racemic propranolol, the plasma levels of the (-)-enantiomer were always lower than those of the (+)-enantiomer with a mean (-):(+) ratio of 0.48. The half-life of the (-)-enantiomer (73.3 +/- 16.2 min) was shorter than that of the (+)-enantiomer (87.1 +/- 18.1 min).

摘要

描述了一种使用带荧光检测的反相高效液相色谱(HPLC)系统,同时定量人血浆和犬血浆中(-)-和(+)-普萘洛尔的简单、快速且灵敏的分析方法。该方法包括在碱性pH条件下,将血浆中的普萘洛尔对映体萃取到正己烷中的1%正丁醇中,然后蒸发有机相,并与手性试剂(-)-氯甲酸薄荷酯形成非对映体衍生物。(+)-氟卡尼用作内标。可检测的每种对映体的极限浓度为1 ng/mL血浆。在6名单次口服80 mg消旋普萘洛尔的正常人类志愿者中,(-)-对映体的血浆水平始终高于(+)-对映体,平均(-):(+)比值为1.38。两种对映体的半衰期相似(3.5±0.3小时)。在6只单次门静脉注射40 mg消旋普萘洛尔的正常雄性杂种犬中,(-)-对映体的血浆水平始终低于(+)-对映体,平均(-):(+)比值为0.48。(-)-对映体的半衰期(73.3±16.2分钟)短于(+)-对映体(87.1±18.1分钟)。

相似文献

1
Simultaneous determination of propranolol enantiomers in plasma by high-performance liquid chromatography with fluorescence detection.高效液相色谱-荧光检测法同时测定血浆中普萘洛尔对映体
J Pharm Sci. 1989 Sep;78(9):771-5. doi: 10.1002/jps.2600780915.
2
Microassay of propranolol enantiomers and conjugates in human plasma and urine by high-performance liquid chromatography after chiral derivatization for pharmacokinetic study.手性衍生化后采用高效液相色谱法对人血浆和尿液中普萘洛尔对映体及其缀合物进行微量分析以用于药代动力学研究。
J Pharm Biomed Anal. 1994 Sep;12(9):1189-98. doi: 10.1016/0731-7085(94)e0028-y.
3
Dispersive liquid-liquid microextraction of propranolol enantiomers from human plasma based on the solidification of a floating organic droplet.基于漂浮有机液滴固化的人血浆中普萘洛尔对映体的分散液液微萃取
Bioanalysis. 2013 Mar;5(6):701-10. doi: 10.4155/bio.13.23.
4
Simultaneous determination of propranolol and 4-hydroxypropranolol enantiomers after chiral derivatization using reversed-phase high-performance liquid chromatography.
J Chromatogr. 1990 May 18;527(2):351-9. doi: 10.1016/s0378-4347(00)82118-0.
5
Simultaneous determination of d- and l-propranolol in human plasma by high-performance liquid chromatography.高效液相色谱法同时测定人血浆中d-和l-普萘洛尔
J Chromatogr. 1980 Nov 14;221(1):109-17. doi: 10.1016/s0378-4347(00)81012-9.
6
Quantification of propranolol enantiomers in small blood samples from rats by reversed-phase high-performance liquid chromatography after chiral derivatization.
J Chromatogr. 1989 Apr 14;489(2):333-43. doi: 10.1016/s0378-4347(00)82911-4.
7
High-performance liquid chromatographic determination of (S)- and (R)-propranolol in human plasma and urine with a chiral beta-cyclodextrin bonded phase.采用手性β-环糊精键合相的高效液相色谱法测定人血浆和尿液中的(S)-和(R)-普萘洛尔
J Chromatogr B Biomed Appl. 1995 Mar 10;665(1):125-32. doi: 10.1016/0378-4347(94)00511-3.
8
Liquid chromatographic analysis of propranolol enantiomers in human blood using precolumn derivatization with (+)-1-(9-fluorenyl)ethyl chloroformate.采用(+)-1-(9-芴基)乙基氯甲酸酯进行柱前衍生化,对人血中普萘洛尔对映体进行液相色谱分析。
J Chromatogr. 1991 Oct 4;570(2):453-61. doi: 10.1016/0378-4347(91)80553-o.
9
Stereoselective high-performance liquid chromatographic assay for propranolol enantiomers in serum.
J Chromatogr. 1989 Mar 24;488(2):407-16. doi: 10.1016/s0378-4347(00)82964-3.
10
Improved enantioselective method for the determination of the enantiomers of reboxetine in plasma by solid-phase extraction, chiral derivatization, and column-switching high-performance liquid chromatography with fluorescence detection.通过固相萃取、手性衍生化和柱切换高效液相色谱荧光检测改进的对映体选择性方法测定血浆中瑞波西汀对映体。
J Chromatogr A. 1998 Dec 18;828(1-2):167-76. doi: 10.1016/s0021-9673(98)00664-5.

引用本文的文献

1
D-Propranolol Impairs EGFR Trafficking and Destabilizes Mutant p53 Counteracting AKT Signaling and Tumor Malignancy.D-普萘洛尔损害表皮生长因子受体(EGFR)转运并使突变型p53不稳定,从而对抗AKT信号传导和肿瘤恶性程度。
Cancers (Basel). 2021 Jul 20;13(14):3622. doi: 10.3390/cancers13143622.
2
Erythrocyte G protein as a novel target for malarial chemotherapy.红细胞G蛋白作为疟疾化疗的新靶点。
PLoS Med. 2006 Dec;3(12):e528. doi: 10.1371/journal.pmed.0030528.
3
Iontophoretic in vivo transdermal delivery of beta-blockers in hairless rats and reduced skin irritation by liposomal formulation.
离子电渗法在无毛大鼠体内经皮递送β受体阻滞剂及脂质体制剂减轻皮肤刺激性
Pharm Res. 2003 Sep;20(9):1496-501. doi: 10.1023/a:1025726715063.
4
Lack of effect of ageing on the stereochemical disposition of propranolol.衰老对普萘洛尔立体化学分布无影响。
Br J Clin Pharmacol. 1992 Jan;33(1):121-3. doi: 10.1111/j.1365-2125.1992.tb04012.x.